Q/C Technologies, Inc. (QCLS) Shareholder Equity
- 2026-06-30: Common Stock, Value, IssuedUSD $8.19K; Additional Paid in CapitalUSD $168.13M; Retained Earnings (Accumulated Deficit)USD $-152.19M; Stockholders' Equity Attributable to ParentUSD $16.09M.
- 2026-03-31: Common Stock, Value, IssuedUSD $7.85K; Additional Paid in CapitalUSD $166.22M; Retained Earnings (Accumulated Deficit)USD $-145.65M; Stockholders' Equity Attributable to ParentUSD $20.72M.
- 2025-12-31: Common Stock, Value, IssuedUSD $7.69K; Additional Paid in CapitalUSD $165.72M; Retained Earnings (Accumulated Deficit)USD $-144.12M; Stockholders' Equity Attributable to ParentUSD $21.75M.
- 2025-09-30: Common Stock, Value, IssuedUSD $179.81K; Additional Paid in CapitalUSD $151.56M; Retained Earnings (Accumulated Deficit)USD $-137.56M; Stockholders' Equity Attributable to ParentUSD $14.32M.
Q/C Technologies, Inc. Shareholder Equity
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Common Stock, Value, Issued USD | Additional Paid in Capital USD | Retained Earnings (Accumulated Deficit) USD | Stockholders' Equity Attributable to Parent USD | Adjustments to Additional Paid in Capital, Equity Component of Convertible Debt USD | Adjustments to Additional Paid in Capital, Other USD | Preferred Stock, Value, Issued USD | Accumulated Other Comprehensive Income (Loss), Net of Tax USD | APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition USD | APIC, Share-based Payment Arrangement, ESPP, Increase for Cost Recognition USD | APIC, Share-based Payment Arrangement, Other, Increase for Cost Recognition USD | APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $8.19K | $168.13M | $-152.19M | $16.09M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2026-03-31 | $7.85K | $166.22M | $-145.65M | $20.72M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-12-31 | $7.69K | $165.72M | $-144.12M | $21.75M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-09-30 | $179.81K | $151.56M | $-137.56M | $14.32M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-06-30 | $29.38K | $138.95M | $-133.85M | $5.28M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-03-31 | $7.39K | $139.62M | $-131.08M | $8.69M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-12-31 | $3.36K | $138.78M | $-129.14M | $9.79M | 12 month · $-4.67M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-09-30 | $2.47K | $142.63M | $-126.00M | $16.78M | (m) | 3 month · $19.31M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-06-30 | $2.37K | $123.27M | $-123.32M | $97.81K | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-06-29 | (m) | (m) | (m) | $97.81K | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-03-31 | $2.16K | $122.77M | $-112.98M | $9.94M | (m) | 3 month · $7.96M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-12-31 | $2.02K | $114.20M | $-101.98M | $12.37M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-09-30 | $112.44M | (m) | $-97.09M | $15.50M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-06-30 | $110.57M | (m) | $-99.97M | $10.74M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-03-31 | $108.38M | (m) | $-95.43M | $13.09M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-12-31 | $1.32K | $108.31M | $-93.76M | $14.70M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-09-30 | $108.20M | (m) | $-90.01M | $18.33M | (m) | (m) | $144.52K | (m) | (m) | (m) | (m) | (m) |
| 2022-06-30 | $102.29M | (m) | $-86.32M | $16.12M | (m) | (m) | $144.52K | (m) | (m) | (m) | (m) | (m) |
| 2022-03-31 | $102.16M | (m) | $-82.68M | $19.62M | (m) | (m) | $144.52K | (m) | (m) | (m) | (m) | (m) |
| 2021-12-31 | $102.06M | (m) | $-78.56M | $23.65M | (m) | (m) | $144.52K | (m) | (m) | (m) | (m) | (m) |
| 2021-09-30 | (m) | (m) | $-75.32M | $25.89M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-06-30 | (m) | (m) | $-69.85M | $31.07M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-03-31 | $171.93M | (m) | $-138.65M | $-8.35M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-12-31 | $4.00K | $43.41M | $-48.67M | $-5.26M | (m) | (m) | (m) | (m) | 12 month · $2.01M | 12 month · $855.00K | 12 month · $1.72M | (m) |
| 2020-09-30 | $154.90M | (m) | $-133.88M | $-4.23M | (m) | (m) | (m) | (m) | 3 month · $272.70K | (m) | (m) | (m) |
| 2020-06-30 | $142.33M | (m) | $-126.75M | $-3.05M | (m) | (m) | (m) | $21.15K | (m) | (m) | (m) | (m) |
| 2020-03-31 | $129.74M | (m) | $-123.12M | $-2.66M | (m) | (m) | (m) | $-223.05K | (m) | (m) | (m) | (m) |
| 2019-12-31 | $128.92M | (m) | $-119.58M | $-2.33M | (m) | (m) | (m) | $17.89K | (m) | (m) | (m) | (m) |
| 2019-12-29 | (m) | (m) | (m) | $-1.73M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2019-11-30 | (m) | (m) | (m) | $-1.73M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2019-09-30 | $121.82M | (m) | $-118.24M | $3.60M | (m) | (m) | (m) | $19.68K | (m) | (m) | (m) | (m) |
| 2019-06-30 | $121.70M | (m) | $-117.41M | $4.31M | (m) | (m) | (m) | $21.49K | (m) | (m) | (m) | (m) |
| 2019-03-31 | $121.57M | (m) | $-116.61M | $4.97M | (m) | (m) | (m) | $3.43K | (m) | (m) | (m) | (m) |
| 2018-12-31 | $121.55M | (m) | $-115.69M | $5.83M | (m) | (m) | (m) | $-25.91K | (m) | (m) | (m) | (m) |
| 2018-09-30 | $119.58M | (m) | $-111.86M | $7.72M | (m) | (m) | (m) | $-5.54K | (m) | (m) | (m) | 3 month · $1.48K |
| 2018-06-30 | $119.58M | (m) | $-108.77M | $10.79M | (m) | (m) | (m) | $-12.44K | (m) | (m) | (m) | 3 month · $2.74K |
| 2018-03-31 | $118.14M | (m) | $-106.71M | $11.42M | (m) | (m) | (m) | $-16.84K | (m) | (m) | (m) | 3 month · $2.71K |
| 2017-12-31 | $110.65M | (m) | $-104.85M | $7.55M | (m) | (m) | $1.75M | (m) | (m) | (m) | (m) | 12 month · $17.27K |
| 2017-09-30 | $104.63M | (m) | $-100.82M | $3.80M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 9 month · $14.50K |
| 2017-06-30 | $104.62M | (m) | $-99.65M | $4.96M | (m) | (m) | (m) | $1.01K | (m) | (m) | (m) | 6 month · $10.18K |
| 2017-03-31 | $104.59M | (m) | $-98.83M | $5.75M | (m) | (m) | (m) | $156.00 | (m) | (m) | (m) | 3 month · $5.04K |
| 2016-12-31 | $100.89M | (m) | $-97.48M | $3.39M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2016-09-30 | $100.89M | (m) | $-96.38M | $4.47M | (m) | (m) | (m) | $-2.54K | (m) | (m) | (m) | (m) |
| 2016-06-30 | $100.85M | (m) | $-96.69M | $4.12M | (m) | (m) | (m) | $297.00 | (m) | (m) | (m) | (m) |
| 2016-03-31 | $100.79M | (m) | $-95.68M | $5.11M | (m) | (m) | (m) | $2.30K | (m) | (m) | (m) | (m) |
| 2015-12-31 | $100.79M | (m) | $-94.18M | $6.60M | (m) | (m) | (m) | $-6.23K | (m) | (m) | (m) | (m) |
| 2015-09-30 | $100.39M | (m) | $-90.60M | $9.80M | (m) | (m) | (m) | $8.84K | (m) | (m) | (m) | (m) |
| 2015-06-30 | $100.39M | (m) | $-88.27M | $12.12M | (m) | (m) | (m) | $3.03K | (m) | (m) | (m) | (m) |
| 2015-04-08 | (m) | (m) | (m) | (m) | (m) | $64.09K | (m) | (m) | (m) | (m) | (m) | (m) |
| 2015-03-31 | $100.39M | (m) | $-86.19M | $14.21M | (m) | (m) | (m) | $6.59K | (m) | (m) | (m) | (m) |
| 2015-03-09 | (m) | (m) | (m) | (m) | (m) | $64.67K | (m) | (m) | (m) | (m) | (m) | (m) |
| 2014-12-31 | $99.69M | (m) | $-84.86M | $14.81M | (m) | (m) | (m) | $-20.12K | (m) | (m) | (m) | (m) |
| 2014-09-30 | $99.69M | (m) | $-83.95M | $15.73M | (m) | (m) | $0.00 | $-11.55K | (m) | (m) | (m) | (m) |
| 2014-06-30 | $99.49M | (m) | $-82.83M | $16.66M | (m) | (m) | $0.00 | $-3.55K | (m) | (m) | (m) | (m) |
| 2014-03-31 | $98.94M | (m) | $-82.32M | $16.62M | (m) | (m) | $0.00 | $-10.87K | (m) | (m) | (m) | (m) |
| 2013-12-31 | $85.84M | (m) | $-81.72M | $4.12M | (m) | (m) | $0.00 | $0.00 | (m) | (m) | (m) | (m) |
| 2012-12-31 | (m) | (m) | (m) | $3.30M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |